“Hepatoprotective Effect Of Epigallocatechin-Gallate (Egcg) And Sorafenib Against Den Induced Hepato Cellular Carcinoma In Experimental Animals”. 2022. Journal of Pharmaceutical Negative Results, November, 921-29. https://www.pnrjournal.com/index.php/home/article/view/3403.